| Attribute | Value | Sources |
|---|---|---|
| Symbol | RPL13 | [1] |
| Name | Ribosomal Protein L13 | [1:1] |
| Chromosome | 16q24.3 | [1:2] |
| NCBI Gene ID | 6142 | [1:3] |
| UniProt ID | P26373 | [2] |
| Gene Type | Protein coding | [1:4] |
| Component | Large (60S) ribosomal subunit | [3] |
RPL13 (Ribosomal Protein L13) encodes an essential ribosomal protein that constitutes a core component of the large 60S ribosomal subunit. As part of the eukaryotic ribosome machinery, RPL13 plays a critical role in protein synthesis, which is fundamental to all cellular processes. While ribosomal proteins were long considered primarily structural components, emerging research has revealed that many have moonlighting functions beyond translation, including roles in DNA repair, cell cycle regulation, and apoptosis [3:1].
In the context of neurodegenerative diseases, ribosomal dysfunction has emerged as a significant pathological contributor. Both Alzheimer's disease (AD) and Parkinson's disease (PD) show profound alterations in translation machinery, with impaired ribosomal function contributing to downstream cellular deficits including disrupted protein homeostasis, stress granule formation, and synaptic dysfunction [4][5].
RPL13 is located in the large subunit of the cytoplasmic ribosome, where it contributes to the structural integrity and functional capacity of the translational apparatus. The eukaryotic ribosome consists of two subunits: the small 40S subunit responsible for mRNA binding and scanning, and the large 60S subunit that catalyzes peptide bond formation [3:2].
RPL13 participates in:
Beyond its canonical role in translation, RPL13 has been implicated in several cellular processes:
Translational dysregulation is a hallmark feature of Alzheimer's disease pathology. Multiple studies have documented reduced global translation in AD brains, with specific defects in the initialization and elongation phases of protein synthesis [4:1].
Mechanistic pathways:
Ribosomal stress and phosphorylation: In AD, cellular stress triggers phosphorylation of eukaryotic translation initiation factor 2α (eIF2α), leading to global translation repression. This stress response affects ribosomal proteins including RPL13, altering their interaction with translation machinery [6].
Stress granule formation: When translation is arrested, untranslated mRNAs complex with RNA-binding proteins to form stress granules. These membrane-less organelles are frequently observed in AD brains and are linked to cellular proteostasis failure [7].
Synaptic protein synthesis deficit: Synapses require local protein synthesis for plasticity and function. RPL13-mediated ribosomal dysfunction particularly affects translation of synaptic proteins, contributing to synaptic failure in AD [8].
Protein homeostasis collapse: The ubiquitin-proteasome system and autophagy are already compromised in AD. Ribosomal dysfunction adds another layer to proteostasis failure, leading to accumulation of misfolded proteins and proteotoxicity [9].
Ribosomal dysfunction in PD has been documented in multiple studies, with particular emphasis on mitochondrial ribosomes and cytoplasmic translation machinery [5:1][10].
Mechanistic pathways:
mTOR pathway dysregulation: PD-linked mutations in genes like LRRK2 and PARK2 affect the mTOR signaling pathway, a major regulator of translation. This leads to altered ribosomal biogenesis and function [5:2].
Alpha-synuclein toxicity: Alpha-synuclein aggregation, the hallmark pathology of PD, directly interferes with ribosomal function. Studies show that alpha-synuclein can bind to ribosomes and inhibit translation [11].
ER stress and unfolded protein response: PD neurons experience chronic endoplasmic reticulum stress. The unfolded protein response (UPR) directly inhibits translation through phosphorylation of eIF2α, affecting ribosomal activity [12].
mRNA surveillance failure: Quality control mechanisms for mRNA translation are compromised in PD, leading to production of aberrant proteins that contribute to aggregation pathology [13].
Several converging mechanisms link ribosomal dysfunction to neurodegeneration:
| Mechanism | Description | Disease Relevance |
|---|---|---|
| eIF2α phosphorylation | Global translation inhibition | AD, PD, ALS |
| Stress granule accumulation | Sequestration of mRNAs and proteins | AD, PD, FTD |
| Mitochondrial translation defect | Energy production failure | PD, AD |
| Synaptic translation loss | Synapse dysfunction | AD, PD |
| Ribosome-associated degradation | Cotranslational quality control failure | AD, PD |
RPL13 is ubiquitously expressed across all tissues, including brain regions affected by neurodegeneration:
The ubiquitous nature of RPL13 means that its dysfunction affects all cell types, though neurons may be particularly vulnerable due to their high metabolic demands and reliance on precise protein homeostasis.
RPL13 interacts with multiple cellular pathways relevant to neurodegeneration:
Understanding ribosomal dysfunction in neurodegeneration opens therapeutic avenues: